Company recalls anticoagulant
SCA Pharmaceuticals has recalled 10 lots of compounded heparin sodium, an anticoagulant packaged in 500 mL or 1000 mL intravenous bags, the Food and Drug Administration announced yesterday. The bags contain the undeclared benzyl alcohol, a preservative that can cause serious adverse reactions in premature and low birth weight infants.
Related News Articles
Headline
Venita Owens, president of Baylor Scott & White Health and Wellness Center, and Andrea Hayes, manager of marketing and public relations for Baylor Scott…
Headline
The University of Utah Health shares how it is using intensive primary care to support patients navigating complex medical and social challenges. LISTEN NOW…
Headline
Early-bird registration rates for the AHA’s Healthier Together Conference end March 31. This inaugural conference on community health…
Headline
“Hospitals are the heart of communities across America for one fundamental reason: They support patients whenever, wherever and however they need care,” writes…
Blog
I have the distinct privilege of serving as chair of the American Hospital Association’s Foster G. McGaw Prize Committee, which awards a prize each year to one…
Headline
Doug Brown, partner with Manatt Health and current chair of the AHA’s Foster G. McGaw Prize Committee, discusses how hospitals are tackling food insecurity,…